Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1960 1
1964 2
1966 1
1967 1
1973 3
1974 1
1975 6
1976 2
1977 3
1978 1
1979 1
1980 3
1981 1
1982 5
1983 1
1985 2
1986 3
1987 9
1988 8
1989 7
1990 14
1991 13
1992 10
1993 11
1994 18
1995 20
1996 23
1997 31
1998 24
1999 17
2000 28
2001 28
2002 33
2003 42
2004 59
2005 86
2006 99
2007 99
2008 112
2009 129
2010 149
2011 175
2012 194
2013 179
2014 195
2015 174
2016 180
2017 186
2018 182
2019 190
2020 214
2021 239
2022 278
2023 250
2024 117

Text availability

Article attribute

Article type

Publication date

Search Results

3,412 results

Results by year

Filters applied: . Clear all
Page 1
Kawasaki Disease, MIS-C and COVID-19.
Huang YH, Kuo HC. Huang YH, et al. Among authors: kuo hc. Children (Basel). 2023 Sep 22;10(10):1587. doi: 10.3390/children10101587. Children (Basel). 2023. PMID: 37892250 Free PMC article.
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study.
Lin WC, Tai WC, Chang CH, Tu CH, Feng IC, Shieh MJ, Chung CS, Yen HH, Chou JW, Wong JM, Liu YH, Huang TY, Chuang CH, Tsai TJ, Chiang FF, Lu CY, Hsu WH, Yu FJ, Chao TH, Wu DC, Ho AS, Lin HH, Feng CL, Wu KL, Wong MW, Tung CC, Lin CC, Chen CC, Hu HM, Lu LS, Wang HS, Wu IC, Kuo HY, Wu JF, Yao Shih H, Ni YH, Tang SL, Chen PH, Wei SC. Lin WC, et al. Among authors: kuo hy. Inflamm Bowel Dis. 2023 Nov 2;29(11):1730-1740. doi: 10.1093/ibd/izac269. Inflamm Bowel Dis. 2023. PMID: 36626567 Free PMC article.
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Xie E, Yeo YH, Scheiner B, Zhang Y, Hiraoka A, Tantai X, Fessas P, de Castro T, D'Alessio A, Fulgenzi CAM, Xu S, Tsai HM, Kambhampati S, Wang W, Keenan BP, Gao X, Xing Z, Pinter M, Lin YJ, Guo Z, Vogel A, Tanaka T, Kuo HY, Kelley RK, Kudo M, Yang JD, Pinato DJ, Ji F. Xie E, et al. Among authors: kuo hy. JAMA Oncol. 2023 Oct 1;9(10):1423-1431. doi: 10.1001/jamaoncol.2023.3284. JAMA Oncol. 2023. PMID: 37615958 Free PMC article.
Defect Inspection Techniques in SiC.
Chen PC, Miao WC, Ahmed T, Pan YY, Lin CL, Chen SC, Kuo HC, Tsui BY, Lien DH. Chen PC, et al. Among authors: kuo hc. Nanoscale Res Lett. 2022 Mar 4;17(1):30. doi: 10.1186/s11671-022-03672-w. Nanoscale Res Lett. 2022. PMID: 35244784 Free PMC article. Review.
Next generation patient derived tumor organoids.
Podaza E, Kuo HH, Nguyen J, Elemento O, Martin ML. Podaza E, et al. Among authors: kuo hh. Transl Res. 2022 Dec;250:84-97. doi: 10.1016/j.trsl.2022.08.003. Epub 2022 Aug 12. Transl Res. 2022. PMID: 35964899 Review.
Current optimal pharmacologic therapies for overactive bladder.
Jiang YH, Kuo HC. Jiang YH, et al. Among authors: kuo hc. Expert Opin Pharmacother. 2023 Sep-Dec;24(18):2005-2019. doi: 10.1080/14656566.2023.2264183. Epub 2024 Jan 5. Expert Opin Pharmacother. 2023. PMID: 37752121 Review.
3,412 results